Vulnerabilities in certain Contec and Epsimed patient monitors can allow people to gain access and potentially manipulate the ...

Some companies use just enough scientific jargon to make false claims sound believable. Or they overstate their products' benefits while understating the risks.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

Mind Medicine (MindMed) has dosed the first subject in the Phase III Panorama study of a proprietary form of lysergide D-tartrate (LSD), MM120 orally disintegrating tablets (ODT), for the treatment of ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

While the data shows crime is down in Edmonton, EPS say perceptions have not caught up and concerns over disorder and safety persist, especially downtown and on transit.

I suspect I’ve been infected by one of the flu-like viruses currently surging in China, though our own Department of Health (DOH) insists there’s no cause for alarm. In other words, there’s no ...

Sen. Michael Bennet accused Kennedy of making the statement during his Senate confirmation hearing to become the nation's top ...

The Republic of Fiji Military Forces has reiterated its zero-tolerance policy on domestic violence, sexual harassment, and ...

COVID-19 hospitalization was twice as likely than that for flu, especially in the first year of the study, in summer, and ...